Mead Johnson Nutrition said today (18 February) that it has closed its previously announced initial public offering of 30m shares of Class A common stock at the public offering price of US$24 per share.


Further, the underwriters of the offering have exercised their over-allotment option and purchased 4.5m additional shares of Class A common stock.


Including the over-allotment, the company sold 34.5m shares in the offering for net proceeds of around $782m, after deducting underwriting discounts, commissions and estimated offering expenses.


The company said that with this over-allotment, it will have 204.5m shares of Class A and Class B common stock outstanding.


Citi, Morgan Stanley, Banc of America Securities, Credit Suisse and JP Morgan acted as joint book-running managers for the offering.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.